|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tang YN, Ding WQ, Guo XJ, Yuan XW, Wang DM
and Song JG: Epigenetic regulation of Smad2 and Smad3 by profilin-2
promotes lung cancer growth and metastasis. Nat Commun. 6:82302015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Valenzuela-Iglesias A, Sharma VP, Beaty
BT, Ding Z, Gutierrez-Millan LE, Roy P, Condeelis JS and
Bravo-Cordero JJ: Profilin1 regulates invadopodium maturation in
human breast cancer cells. Eur J Cell Biol. 94:78–89. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Coumans JVF, Gau D, Poljak A, Wasinger V,
Roy P and Moens PDJ: Profilin-1 overexpression in MDA-MB-231 breast
cancer cells is associated with alterations in proteomics
biomarkers of cell proliferation, survival, and motility as
revealed by global proteomics analyses. OMICS. 18:778–791. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Boyl Pilo P, Di Nardo A, Mulle C,
Sassoè-Pognetto M, Panzanelli P, Mele A, Kneussel M, Costantini V,
Perlas E, Massimi M, et al: Profilin2 contributes to synaptic
vesicle exocytosis, neuronal excitability, and novelty-seeking
behavior. EMBO J. 26:2991–3002. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yue B, Sun B, Liu C, Zhao S, Zhang D, Yu F
and Yan D: Long non-coding RNA Fer-1-like protein 4 suppresses
oncogenesis and exhibits prognostic value by associating with
miR-106a-5p in colon cancer. Cancer Sci. 106:1323–1332. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Singh A and Settleman J: EMT, cancer stem
cells and drug resistance: An emerging axis of evil in the war on
cancer. Oncogene. 29:4741–4751. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yao D, Dai C and Peng S: Mechanism of the
mesenchymal-epithelial transition and its relationship with
metastatic tumor formation. Mol Cancer Res. 9:1608–1620. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kim MJ, Lee YS, Han GY, Lee HN, Ahn C and
Kim CW: Profilin 2 promotes migration, invasion, and stemness of
HT29 human colorectal cancer stem cells. Biosci Biotechnol Biochem.
79:1438–1446. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cui XB, Zhang SM, Xu YX, Dang HW, Liu CX,
Wang LH, Yang L, Hu JM, Liang WH, Jiang JF, et al: PFN2, a novel
marker of unfavorable prognosis, is a potential therapeutic target
involved in esophageal squamous cell carcinoma. J Transl Med.
14:1372016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li W, Liu C, Zhao C, Zhai L and Lv S:
Downregulation of β3 integrin by miR-30a-5p modulates cell adhesion
and invasion by interrupting Erk/Ets-1 network in triple-negative
breast cancer. Int J Oncol. 48:1155–1164. 2016.PubMed/NCBI
|
|
12
|
Li WF, Dai H, Ou Q, Zuo GQ and Liu CA:
Overexpression of microRNA-30a-5p inhibits liver cancer cell
proliferation and induces apoptosis by targeting MTDH/PTEN/AKT
pathway. Tumour Biol. 37:5885–5895. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Oksuz Z, Serin MS, Kaplan E, Dogen A,
Tezcan S, Aslan G, Emekdas G, Sezgin O, Altintas E and Tiftik EN:
Serum microRNAs; miR-30c-5p, miR-223-3p, miR-302c-3p and miR-17-5p
could be used as novel non-invasive biomarkers for HCV-positive
cirrhosis and hepatocellular carcinoma. Mol Biol Rep. 42:713–720.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Balci S, Ayaz L, Gorur A, Yaroglu Yildirim
H, Akbayir S, Dogruer Unal N, Bulut B, Tursen U and Tamer L:
microRNA profiling for early detection of non-melanoma skin cancer.
Clin Exp Dermatol. 41:346–351. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xie K, Wang C, Qin N, Yang J, Zhu M, Dai
J, Jin G, Shen H, Ma H and Hu Z: Genetic variants in regulatory
regions of microRNAs are associated with lung cancer risk.
Oncotarget. 7:47966–47974. 2016.PubMed/NCBI
|
|
16
|
Zhu J, Zeng Y, Xu C, Qin H, Lei Z, Shen D,
Liu Z and Huang JA: Expression profile analysis of microRNAs and
downregulated miR-486-5p and miR-30a-5p in non-small cell lung
cancer. Oncol Rep. 34:1779–1786. 2015.PubMed/NCBI
|
|
17
|
He R, Yang L, Lin X, Chen X, Lin X, Wei F,
Liang X, Luo Y, Wu Y, Gan T, et al: MiR-30a-5p suppresses cell
growth and enhances apoptosis of hepatocellular carcinoma cells via
targeting AEG-1. Int J Clin Exp Pathol. 8:15632–15641.
2015.PubMed/NCBI
|
|
18
|
Xiong J, Wei B, Ye Q and Liu W:
MiR-30a-5p/UBE3C axis regulates breast cancer cell proliferation
and migration. Biochem Biophys Res Commun. Mar 18–2016.(Epub ahead
of print). doi: 10.1016/j.bbrc.2016.03.069. View Article : Google Scholar
|
|
19
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tafsiri E, Darbouy M, Shadmehr MB, Cho WC
and Karimipoor M: Abberent expression of oncogenic and
tumor-suppressive microRNAs and their target genes in human
adenocarcinoma alveolar basal epithelial cells. J Cancer Res Ther.
12:395–400. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pastorkova Z, Skarda J and Andel J: The
role of microRNA in metastatic processes of non-small cell lung
carcinoma. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub.
160:343–357. 2016.PubMed/NCBI
|
|
23
|
Mao M, Wu Z and Chen J: MicroRNA-187-5p
suppresses cancer cell progression in non-small cell lung cancer
(NSCLC) through down-regulation of CYP1B1. Biochem Biophys Res
Commun. 478:649–655. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kumarswamy R, Mudduluru G, Ceppi P,
Muppala S, Kozlowski M, Niklinski J, Papotti M and Allgayer H:
MicroRNA-30a inhibits epithelial-to-mesenchymal transition by
targeting Snai1 and is downregulated in non-small cell lung cancer.
Int J Cancer. 130:2044–2053. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yuan Y, Zheng S, Li Q, Xiang X, Gao T, Ran
P, Sun L, Huang Q, Xie F, Du J, et al: Overexpression of miR-30a in
lung adenocarcinoma A549 cell line inhibits migration and invasion
via targeting EYA2. Acta Biochim Biophys Sin (Shanghai).
48:220–228. 2016. View Article : Google Scholar : PubMed/NCBI
|
